The EU could soon sign a contract withPfizerfor 1,8 billion additional doses of its anti-Covid vaccine. With deliveries possible until 2023, such a quantity should be enough to vaccinate the entire European population several times over. This is a commercial triumph for the American pharma giant, which has now asserted its supremacy over the European market, as well as for the German laboratoryBioNTechwhich co-produced the famous vaccineComirnaty.
ForAstraZeneca, it’s the descent into hell. After renaming its vaccine in an attempt to restore its image to escape controversy, the Anglo-Swedish pharmaceutical group is being sued by Brussels for its multiple delivery delays with a lawsuit filed on April 23 by the Commission with the approval of the Member States.
Since the signing of the contract, only a third of the promised doses have been delivered, procrastination that letPfizertake a head start…
View original post 439 more words